JPH10503842A - プロラクチンの日毎のリズムを決定及び調節するための改善された方法 - Google Patents

プロラクチンの日毎のリズムを決定及び調節するための改善された方法

Info

Publication number
JPH10503842A
JPH10503842A JP8503515A JP50351596A JPH10503842A JP H10503842 A JPH10503842 A JP H10503842A JP 8503515 A JP8503515 A JP 8503515A JP 50351596 A JP50351596 A JP 50351596A JP H10503842 A JPH10503842 A JP H10503842A
Authority
JP
Japan
Prior art keywords
prolactin
subject
level
healthy
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8503515A
Other languages
English (en)
Japanese (ja)
Inventor
シンコッタ，アンソニー・エイチ
マイアー，アルバート・エイチ
Original Assignee
エルゴ・サイエンス・インコーポレイテッド
ザ・ボード・オブ・スーパーバイザーズ・オブ・ルイジアナ・ステート・ユニバーシティー・アンド・アグリカルチュラル・アンド・メカニカル・カレッジ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エルゴ・サイエンス・インコーポレイテッド, ザ・ボード・オブ・スーパーバイザーズ・オブ・ルイジアナ・ステート・ユニバーシティー・アンド・アグリカルチュラル・アンド・メカニカル・カレッジ filed Critical エルゴ・サイエンス・インコーポレイテッド
Publication of JPH10503842A publication Critical patent/JPH10503842A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Eye Examination Apparatus (AREA)
  • Control Of Transmission Device (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
JP8503515A 1994-06-23 1995-06-23 プロラクチンの日毎のリズムを決定及び調節するための改善された方法 Pending JPH10503842A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26455894A 1994-06-23 1994-06-23
US264,558 1994-06-23
PCT/US1995/009061 WO1996000396A1 (en) 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms

Publications (1)

Publication Number Publication Date
JPH10503842A true JPH10503842A (ja) 1998-04-07

Family

ID=23006606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8503515A Pending JPH10503842A (ja) 1994-06-23 1995-06-23 プロラクチンの日毎のリズムを決定及び調節するための改善された方法

Country Status (14)

Country Link
EP (1) EP0769148A1 (es)
JP (1) JPH10503842A (es)
AU (1) AU3101395A (es)
BR (1) BR9508366A (es)
CA (1) CA2192855A1 (es)
CZ (1) CZ378796A3 (es)
FI (1) FI965146A0 (es)
HU (1) HUT76976A (es)
IL (1) IL114300A0 (es)
MX (1) MX9700225A (es)
NO (1) NO965507L (es)
SK (1) SK167396A3 (es)
WO (1) WO1996000396A1 (es)
ZA (1) ZA955192B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
WO2008157845A1 (en) 2007-06-21 2008-12-24 Veroscience, Llc Method of treating metabolic disorders and depression with dopamine receptor agonists
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
US5066526A (en) * 1987-11-19 1991-11-19 Exxon Chemical Patents Inc. Thermoplastic films for use in stretch/cling applications
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Also Published As

Publication number Publication date
FI965146A (fi) 1996-12-20
HU9603543D0 (en) 1997-02-28
HUT76976A (hu) 1998-01-28
IL114300A0 (en) 1995-10-31
CZ378796A3 (en) 1997-09-17
EP0769148A1 (en) 1997-04-23
WO1996000396A1 (en) 1996-01-04
SK167396A3 (en) 1997-11-05
NO965507D0 (no) 1996-12-20
AU3101395A (en) 1996-01-19
NO965507L (no) 1997-02-11
MX9700225A (es) 1997-04-30
BR9508366A (pt) 1997-09-30
ZA955192B (en) 1996-05-07
FI965146A0 (fi) 1996-12-20
CA2192855A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
US5585347A (en) Methods for the determination and adjustment of prolactin daily rhythms
US5731312A (en) Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5716962A (en) Process for therapeutically modifying and resetting prolactin rhythm with a dopamine agonist
JPH10507159A (ja) 脂質代謝疾患の治療に対するピレンゼピン、メチルスコポラミン及び他のムスカリン性受容体アンタゴニストの投与法
JPH11507385A (ja) グルコース代謝の調節法
JPH1072372A (ja) プロラクチン阻害化合物を含む医薬
JPH11507384A (ja) ドーパミンベータヒドロキシラーゼ阻害剤を用いた代謝の調節法
JP2007332163A (ja) プロラクチンモジュレータ及びダイエットを利用して肥満を治療する方法
US5830895A (en) Methods for the determination and adjustment of prolactin daily rhythms
PT934069E (pt) Método e composição para o tratamento de perturbações do metabolismo dos lípidos e glucose
JP2000513337A (ja) ドーパミン及びセロトニンアゴニストによる脂質及びグルコース代謝障害の治療
JP2007291139A (ja) 脂質及びグルコースの代謝疾患治療剤及び組成物
RU2104698C1 (ru) Способ лечения патологических отклонений при диабете типа ii
JPH10503842A (ja) プロラクチンの日毎のリズムを決定及び調節するための改善された方法
WO1997017083A1 (en) Method for treating obesity and type ii diabetes by adjusting the circadian rhythm of human growth hormone